Neurocognition and neuroimaging of persistent negative symptoms of schizophrenia

References

• Addington J, Addington D. Positive and negative symptoms of schizophrenia – their course and relationship over time. Schizophr. Res.5(1), 51–59 (1991).
   PubMed Web of Science ®Google Scholar
• Herbener ES, Harrow M. Are negative symptoms associated with functioning deficits in both schizophrenia and nonschizophrenia patients? A 10 year longitudinal analysis. Schizophr. Bull.30(4), 813–825 (2004).
   PubMed Web of Science ®Google Scholar
• Mancevski B, Keilp J, Kurzon M et al. Lifelong course of positive and negative symptoms in chronically institutionalized patients with schizophrenia. Psychopathology40(2), 83–92 (2007).
   PubMed Web of Science ®Google Scholar
• McGurk SR, Moriarty PJ, Harvey PD, Parrella M, White L, Davis KL. The longitudinal relationship of clinical symptoms, cognitive functioning, and adaptive life in geriatric schizophrenia. Schizophr. Res.42(1), 47–55 (2000).
   PubMed Web of Science ®Google Scholar
• Potkin SG, Alva G, Fleming K et al. A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography. Am. J. Psychiatry159(2), 227–237 (2002).
   PubMed Web of Science ®Google Scholar
• Ho BC, Nopoulos P, Flaum M, Arndt S, Andreasen NC. Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life. Am. J. Psychiatry155(9), 1196–1201 (1998).
   PubMed Web of Science ®Google Scholar
• O’Leary DS, Flaum M, Kesler ML, Flashman LA, Arndt S, Andreasen NC. Cognitive correlates of the negative, disorganized, and psychotic symptom dimensions of schizophrenia. J. Neuropsychiatry Clin. Neurosci.12(1), 4–15 (2000).
   PubMed Web of Science ®Google Scholar
• Sanfilipo M, Lafargue T, Rusinek H et al. Volumetric measure of the frontal and temporal lobe regions in schizophrenia – relationship to negative symptoms. Arch. Gen. Psychiatry57(5), 471–480 (2000).
   PubMed Web of Science ®Google Scholar
• Wible CG, Anderson J, Shenton ME et al. Prefrontal cortex, negative symptoms, and schizophrenia: an MRI study. Psychiatry Res. Neuroimaging108(2), 65–78 (2001).
   PubMed Web of Science ®Google Scholar
• Zetzsche T, Preuss UW, Frodl T et al. White matter alterations in schizophrenic patients with pronounced negative symptomatology and with positive family history for schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci.258(5), 278–284 (2008).
   PubMedGoogle Scholar
• Kirkpatrick B, Fenton WS, Carpenter WT, Marder SR. The NIMH-MATRICS consensus statement on negative symptoms. Schizophr. Bull.32(2), 214–219 (2006).
   PubMed Web of Science ®Google Scholar
• Kirkpatrick B, Buchanan RW, McKenney PD, Alphs LD, Carpenter WT Jr. The schedule for the deficit syndrome: an instrument for research in schizophrenia. Psychiatry Res.30(2), 119–123 (1989).
   PubMed Web of Science ®Google Scholar
• Tandon R, DeQuardo JR, Taylor SF et al. Phasic and enduring negative symptoms in schizophrenia: biological markers and relationship to outcome. Schizophr. Res.45(3), 191–201 (2000).
   PubMed Web of Science ®Google Scholar
• Castellon SA, Asarnow RF, Goldstein MJ, Marder SR. Persisting negative symptoms and information-processing deficits in schizophrenia – implications for subtyping. Psychiatry Res.54(1), 59–69 (1994).
   PubMedGoogle Scholar
• Ho BC, Andreasen NC, Nopoulos P, Arndt S, Magnotta V, Flaum M. Progressive structural brain abnormalities and their relationship to clinical outcome – a longitudinal magnetic resonance imaging study early in schizophrenia. Arch. Gen. Psychiatry60(6), 585–594 (2003).
   PubMed Web of Science ®Google Scholar
• Bell MD, Mishara AL. Does negative symptom change relate to neurocognitive change in schizophrenia? Implications for targeted treatments. Schizophr. Res.81(1), 17–27 (2006).
   PubMed Web of Science ®Google Scholar
• Tsai J, Lysaker PH, Vohs JL. Negative symptoms and concomitant attention deficits in schizophrenia: associations with prospective assessments of anxiety, social dysfunction, and avoidant coping. J. Mental Health19(2), 184–192 (2010).
   PubMed Web of Science ®Google Scholar
• Bottlender R, Sato T, Groll C, Jager M, Kunze I, Moller HJ. Negative symptoms in depressed and schizophrenic patients: how do they differ? J. Clin. Psychiatry64(8), 954–958 (2003).
   PubMed Web of Science ®Google Scholar
• Pluck GC, Brown RG. Apathy in Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry73(6), 636–642 (2002).
   PubMed Web of Science ®Google Scholar
• Reichman WE, Negron A. Negative symptoms in the elderly patient with dementia. Int. J. Geriatr. Psychiatry16(Suppl. 1), S7–S11 (2001).
   PubMed Web of Science ®Google Scholar
• Peterson CB, Thuras P, Ackard DM et al. Personality dimensions in bulimia nervosa, binge eating disorder, and obesity. Compr. Psychiatry51(1), 31–36 (2010).
   PubMed Web of Science ®Google Scholar
• Pfeifer S, van Os J, Hanssen M, Delespaul P, Krabbendam L. Subjective experience of cognitive failures as possible risk factor for negative symptoms of psychosis in the general population. Schizophr. Bull.35(4), 766–774 (2009).
   PubMed Web of Science ®Google Scholar
• Bobes J, Arango C, Garcia-Garcia M, Rejas J; CLAMORS Study Collaborative Group. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS Study. J. Clin. Psychiatry71(3), 280–286 (2010).
   PubMed Web of Science ®Google Scholar
• Herbener ES, Harrow M. Longitudinal assessment of negative symptoms in schizophrenia/schizoaffective patients, other psychotic patients, and depressed patients. Schizophr. Bull.27(3), 527–537 (2001).
   PubMed Web of Science ®Google Scholar
• Alphs L, Panagides J, Lancaster S. Asenapine in the treatment of negative symptoms of schizophrenia: clinical trial design and rationale. Psychopharmacol. Bull.40(2), 41–53 (2007).
   PubMed Web of Science ®Google Scholar
• Makinen J, Miettunen J, Isohanni M, Koponen H. Negative symptoms in schizophrenia: a review. Nord. J. Psychiatry62(5), 334–341 (2008).
   PubMed Web of Science ®Google Scholar
• Remington G, Agid O, Foussias G. Schizophrenia as a disorder of too little dopamine: implications for symptoms and treatment. Expert Rev. Neurother.11(4), 589–607 (2011).
   PubMed Web of Science ®Google Scholar
• Selten JP, Wiersma D, van den Bosch RJ. Distress attributed to negative symptoms in schizophrenia. Schizophr. Bull.26(3), 737–744 (2000).
   PubMed Web of Science ®Google Scholar
• Compton MT, Carter T, Bergner E et al. Defining, operationalizing and measuring the duration of untreated psychosis: advances, limitations and future directions. Early Interv. Psychiatry1(3), 236–250 (2007).
   Web of Science ®Google Scholar
• Fenton WS, McGlashan TH. Antecedents, symptom progression, and long-term outcome of the deficit syndrome in schizophrenia. Am. J. Psychiatry151(3), 351–356 (1994).
   PubMed Web of Science ®Google Scholar
• Murphy BP, Chung YC, Park TW, McGorry PD. Pharmacological treatment of primary negative symptoms in schizophrenia: a systematic review. Schizophr. Res.88(1–3), 5–25 (2006).
   PubMed Web of Science ®Google Scholar
• Buchanan RW, Breier A, Kirkpatrick B et al. Structural abnormalities in deficit and nondeficit schizophrenia. Am. J. Psychiatry150(1), 59–65 (1993).
   PubMed Web of Science ®Google Scholar
• Keefe RSE, Mohs RC, Davidson M et al. Kraepelinian schizophrenia – a subgroup of schizophrenia. Psychopharmacol. Bull.24(1), 56–61 (1988).
   PubMedGoogle Scholar
• Nakaya M, Ohmori K. Kraepelinian subtype and deficit syndrome in chronic schizophrenia. Psychiatry Res.144(2–3), 221–225 (2006).
   PubMed Web of Science ®Google Scholar
• Husted JA, Beiser M, Iacono WG. Negative symptoms in the course of first-episode affective psychosis. Psychiatry Res.56(2), 145–154 (1995).
   PubMedGoogle Scholar
• Hovington CL, Bodnar M, Joober R, Malla A, Lepage M. Prevalence of persistent negative symptoms in first episode psychosis: a comparison of 3 definitions and their relation to cognition and functional outcome. Schizophr. Bull.36(Suppl. 1), 244–245 (2011).
   Google Scholar
• Buchanan RW. Persistent negative symptoms in schizophrenia: an overview. Schizophr. Bull.33(4), 1013–1022 (2007).
   PubMed Web of Science ®Google Scholar
• Malla AK, Norman RM, Takhar J et al. Can patients at risk for persistent negative symptoms be identified during their first episode of psychosis? J. Nerv. Ment. Dis.192(7), 455–463 (2004).
   PubMed Web of Science ®Google Scholar
• Edwards J, McGorry PD, Waddell FM, Harrigan SM. Enduring negative symptoms in first-episode psychosis: comparison of six methods using follow-up data. Schizophr. Res.40(2), 147–158 (1999).
   PubMed Web of Science ®Google Scholar
• McGlashan TH, Quinlan D, Glazer W, Schuldberg D. Cognitive functioning and persistently high negative symptoms in chronic schizophrenia. Schizophr. Res.24(1–2), 115 (1997).
   Google Scholar
• Foussias G, Remington G. Negative symptoms in schizophrenia: avolition and Occam’s razor. Schizophr. Bull.36(2), 359–369 (2010).
   PubMed Web of Science ®Google Scholar
• Ke M, Zou R, Shen H et al. Bilateral functional asymmetry disparity in positive and negative schizophrenia revealed by resting-state fMRI. Psychiatry Res.182(1), 30–39 (2010).
   PubMedGoogle Scholar
• Puri BK. Progressive structural brain changes in schizophrenia. Expert Rev. Neurother.10(1), 33–42 (2010).
   PubMed Web of Science ®Google Scholar
• Hulshoff Pol HE, Kahn RS. What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia. Schizophr. Bull.34(2), 354–366 (2008).
   PubMed Web of Science ®Google Scholar
• Shenton ME, Dickey CC, Frumin M, McCarley RW. A review of MRI findings in schizophrenia. Schizophr. Res.49(1–2), 1–52 (2001).
   PubMed Web of Science ®Google Scholar
• Lim KO, Hedehus M, Moseley M, de Crespigny A, Sullivan EV, Pfefferbaum A. Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. Arch. Gen. Psychiatry56(4), 367–374 (1999).
   PubMed Web of Science ®Google Scholar
• Kubicki M, McCarley R, Westin CF et al. A review of diffusion tensor imaging studies in schizophrenia. J. Psychiatric Res.41(1–2), 15–30 (2007).
   PubMed Web of Science ®Google Scholar
• Takahashi T, Kosaka H, Murata T et al. Application of a multifractal analysis to study brain white matter abnormalities of schizophrenia on T2-weighted magnetic resonance imaging. Psychiatry Res.171(3), 177–188 (2009).
   PubMedGoogle Scholar
• Kuperberg GR, Broome MR, McGuire PK et al. Regionally localized thinning of the cerebral cortex in schizophrenia. Arch. Gen. Psychiatry60(9), 878–888 (2003).
   PubMed Web of Science ®Google Scholar
• Schultz CC, Koch K, Wagner G et al. Complex pattern of cortical thinning in schizophrenia: results from an automated surface based analysis of cortical thickness. Psychiatry Res.182(2), 134–140 (2010).
   PubMed Web of Science ®Google Scholar
• Koutsouleris N, Gaser C, Jager M et al. Structural correlates of psychopathological symptom dimensions in schizophrenia: a voxel-based morphometric study. Neuroimage39(4), 1600–1612 (2008).
   PubMed Web of Science ®Google Scholar
• Kirkpatrick B, Buchanan RW, Ross DE, Carpenter WT Jr. A separate disease within the syndrome of schizophrenia. Arch. Gen. Psychiatry58(2), 165–171 (2001).
   PubMed Web of Science ®Google Scholar
• Galderisi S, Quarantelli M, Volpe U et al. Patterns of structural MRI abnormalities in deficit and nondeficit schizophrenia. Schizophr. Bull.34(2), 393–401 (2008).
   PubMed Web of Science ®Google Scholar
• Quarantelli M, Larobina M, Volpe U et al. Stereotaxy-based regional brain volumetry applied to segmented MRI: validation and results in deficit and nondeficit schizophrenia. Neuroimage17(1), 373–384 (2002).
   PubMedGoogle Scholar
• Cascella NG, Fieldstone SC, Rao VA, Pearlson GD, Sawa A, Schretlen DJ. Gray-matter abnormalities in deficit schizophrenia. Schizophr. Res.120(1–3), 63–70 (2010).
   PubMed Web of Science ®Google Scholar
• Yoshida T, McCarley RW, Nakamura M et al. A prospective longitudinal volumetric MRI study of superior temporal gyrus gray matter and amygdala–hippocampal complex in chronic schizophrenia. Schizophr. Res.113(1), 84–94 (2009).
   PubMed Web of Science ®Google Scholar
• Shenton ME, Gerig G, McCarley RW, Szekely G, Kikinis R. Amygdala–hippocampal shape differences in schizophrenia: the application of 3D shape models to volumetric MR data. Psychiatry Res.115(1–2), 15–35 (2002).
   PubMed Web of Science ®Google Scholar
• Anderson JE, Wible CG, McCarley RW, Jakab M, Kasai K, Shenton ME. An MRI study of temporal lobe abnormalities and negative symptoms in chronic schizophrenia. Schizophr. Res.58(2–3), 123–134 (2002).
   PubMed Web of Science ®Google Scholar
• Meisenzahl EM, Koutsouleris N, Bottlender R et al. Structural brain alterations at different stages of schizophrenia: a voxel-based morphometric study. Schizophr. Res.104(1–3), 44–60 (2008).
   PubMedGoogle Scholar
• Sigmundsson T, Suckling J, Maier M et al. Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms. Am. J. Psychiatry158(2), 234–243 (2001).
   PubMed Web of Science ®Google Scholar
• Meduri M, Bramanti P, Ielitro G et al. Morphometrical and morphological analysis of lateral ventricles in schizophrenia patients versus healthy controls. Psychiatry Res.183(1), 52–58 (2010).
   PubMedGoogle Scholar
• Sharma T, Lancaster E, Lee D et al. Brain changes in schizophrenia. Volumetric MRI study of families multiply affected with schizophrenia – the Maudsley Family Study 5. Br. J. Psychiatry173, 132–138 (1998).
   PubMed Web of Science ®Google Scholar
• Saijo T, Abe T, Someya Y et al. Ten year progressive ventricular enlargement in schizophrenia: an MRI morphometrical study. Psychiatry Clin. Neurosci.55(1), 41–47 (2001).
   PubMedGoogle Scholar
• Gur RE, Mozley PD, Shtasel DL et al. Clinical subtypes of schizophrenia: differences in brain and CSF volume. Am. J. Psychiatry151(3), 343–350 (1994).
   PubMed Web of Science ®Google Scholar
• Ebdrup BH, Skimminge A, Rasmussen H et al. Progressive striatal and hippocampal volume loss in initially antipsychotic-naive, first-episode schizophrenia patients treated with quetiapine: relationship to dose and symptoms. Int. J. Neuropsychopharmacol.14(1), 69–82 (2011).
   PubMed Web of Science ®Google Scholar
• Malla AK, Takhar JJ, Norman RMG et al. Negative symptoms in first episode non-affective psychosis. Acta Psychiatr. Scand.105(6), 431–439 (2002).
   PubMed Web of Science ®Google Scholar
• Crespo-Facorro B, Roiz-Santianez R, Pelayo-Teran JM et al. Reduced thalamic volume in first-episode non-affective psychosis: correlations with clinical variables, symptomatology and cognitive functioning. Neuroimage35(4), 1613–1623 (2007).
   PubMed Web of Science ®Google Scholar
• Nieuwenstein MR, Aleman A, de Haan EHF. Relationship between symptom dimensions and neurocognitive functioning in schizophrenia: a meta-analysis of WCST and CPT studies. J. Psychiatric Res.35(2), 119–125 (2001).
   PubMed Web of Science ®Google Scholar
• Harvey PD, Koren D, Reichenberg A, Bowie CR. Negative symptoms and cognitive deficits: what is the nature of their relationship? Schizophr. Bull.32(2), 250–258 (2006).
   PubMed Web of Science ®Google Scholar
• Aleman A, Hijman R, de Haan EHF, Kahn RS. Memory impairment in schizophrenia: a meta-analysis. Am. J. Psychiatry156(9), 1358–1366 (1999).
   PubMed Web of Science ®Google Scholar
• Dibben CRM, Rice C, Laws K, McKenna PJ. Is executive impairment associated with schizophrenic syndromes? A meta-analysis. Psychol. Med.39(3), 381–392 (2009).
   PubMed Web of Science ®Google Scholar
• Bora E, Yucel M, Pantelis C. Cognitive functioning in schizophrenia, schizoaffective disorder and affective psychoses: meta-analytic study. Br. J. Psychiatry195(6), 475–482 (2009).
   PubMed Web of Science ®Google Scholar
• Hughes C, Kumari V, Soni W et al. Longitudinal study of symptoms and cognitive function in chronic schizophrenia. Schizophr. Res.59(2–3), 137–146 (2003).
   PubMed Web of Science ®Google Scholar
• Cohen AS, Saperstein AM, Gold JM et al. Neuropsychology of the deficit syndrome: new data and meta-analysis of findings to date. Schizophr. Bull.33(5), 1201–1212 (2007).
   PubMed Web of Science ®Google Scholar
• Wang X, Yao S, Kirkpatrick B, Shi C, Yi J. Psychopathology and neuropsychological impairments in deficit and nondeficit schizophrenia of Chinese origin. Psychiatry Res.158(2), 195–205 (2008).
   PubMedGoogle Scholar
• Bryson G, Whelahan HA, Bell M. Memory and executive function impairments in deficit syndrome schizophrenia. Psychiatry Res.102(1), 29–37 (2001).
   PubMed Web of Science ®Google Scholar
• Cascella NG, Testa SM, Meyer SM et al. Neuropsychological impairment in deficit vs. non-deficit schizophrenia. J. Psychiatric Res.42(11), 930–937 (2008).
   PubMedGoogle Scholar
• Galderisi S, Maj M, Mucci A et al. Historical, psychopathological, neurological, and neuropsychological aspects of deficit schizophrenia: a multicenter study. Am. J. Psychiatry159(6), 983–990 (2002).
   PubMed Web of Science ®Google Scholar
• Polgar P, Rethelyi JM, Balint S, Komlosi S, Czobor P, Bitter I. Executive function in deficit schizophrenia: what do the dimensions of the Wisconsin Card Sorting Test tell us? Schizophr. Res.122(1–3), 85–93 (2010).
   PubMedGoogle Scholar
• Heydebrand G, Weiser M, Rabinowitz J, Hoff AL, DeLisi LE, Csernansky JG. Correlates of cognitive deficits in first episode schizophrenia. Schizophr. Res.68(1), 1–9 (2004).
   PubMed Web of Science ®Google Scholar
• Bilder RM, Goldman RS, Robinson D et al. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. Am. J. Psychiatry157(4), 549–559 (2000).
   PubMed Web of Science ®Google Scholar
• Milev P, Ho BC, Arndt S, Andreasen NC. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am. J. Psychiatry162(3), 495–506 (2005).
   PubMed Web of Science ®Google Scholar
• van den Heuvel MP, Hulshoff Pol HE. Exploring the brain network: a review on resting-state fMRI functional connectivity. Eur. Neuropsychopharmacol.20(8), 519–534 (2010).
   PubMed Web of Science ®Google Scholar
• Gruzelier JH. Functional neuropsychophysiological asymmetry in schizophrenia: a review and reorientation. Schizophr. Bull.25(1), 91–120 (1999).
   PubMed Web of Science ®Google Scholar
• Bluhm RL, Miller J, Lanius RA et al. Spontaneous low-frequency fluctuations in the BOLD signal in schizophrenic patients: anomalies in the default network. Schizophr. Bull.33(4), 1004–1012 (2007).
   PubMed Web of Science ®Google Scholar
• Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL. A default mode of brain function. Proc. Natl Acad. Sci. USA98(2), 676–682 (2001).
   PubMed Web of Science ®Google Scholar
• Honey GD, Pomarol-Clotet E, Corlett PR et al. Functional dysconnectivity in schizophrenia associated with attentional modulation of motor function. Brain128, 2597–2611 (2005).
   PubMed Web of Science ®Google Scholar
• Fahim C, Stip E, Mancini-Marie A et al. Brain activity during emotionally negative pictures in schizophrenia with and without flat affect: an fMRI study. Psychiatry Res.140(1), 1–15 (2005).
   PubMed Web of Science ®Google Scholar
• Lepage M, Sergerie K, Benoit A, Czechowska Y, Dickie E, Armony JL. Emotional face processing and flat affect in schizophrenia: functional and structural neural correlates. Psychol. Med.41(9), 1833–1844 (2011).
   PubMedGoogle Scholar
• Kosaka H, Omori M, Murata T et al. Differential amygdala response during facial recognition in patients with schizophrenia: an fMRI study. Schizophr. Res.57(1), 87–95 (2002).
   PubMed Web of Science ®Google Scholar
• Carlsson A, Waters N, Carlsson ML. Neurotransmitter interactions in schizophrenia-therapeutic implications. Eur. Arch. Psychiatry Clin. Neurosci.249, 37–43 (1999).
   PubMedGoogle Scholar
• Juckel G, Schlagenhauf F, Koslowski M et al. Dysfunction of ventral striatal reward prediction in schizophrenia. Neuroimage29(2), 409–416 (2006).
   PubMed Web of Science ®Google Scholar
• Kumari V, Fannon D, Ffytche DH et al. Functional MRI of verbal self-monitoring in schizophrenia: performance and illness-specific effects. Schizophr. Bull.36(4), 740–755 (2010).
   PubMed Web of Science ®Google Scholar
• Harvey PO, Armony J, Malla A, Lepage M. Functional neural substrates of self-reported physical anhedonia in non-clinical individuals and in patients with schizophrenia. J. Psychiatric Res.44(11), 707–716 (2010).
   PubMedGoogle Scholar
• Menon V, Anagnoson RT, Mathalon DH, Glover GH, Pfefferbaum A. Functional neuroanatomy of auditory working memory in schizophrenia: relation to positive and negative symptoms. Neuroimage13(3), 433–446 (2001).
   PubMed Web of Science ®Google Scholar
• Andreasen NC, Rezai K, Alliger R et al. Hypofrontality in neuroleptic-naive patients and in patients with chronic-schizophrenia – assessment with Xe-133 single-photon emission computed-tomography and the Tower of London. Arch. Gen. Psychiatry49(12), 943–958 (1992).
   PubMed Web of Science ®Google Scholar
• van Veelen NMJ, Vink M, Ramsey NF, Kahn RS. Left dorsolateral prefrontal cortex dysfunction in medication-naive schizophrenia. Schizophr. Res.123(1), 22–29 (2010).
   PubMedGoogle Scholar
• Kapur S, Remington G. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia. Annu. Rev. Med.52, 503–517 (2001).
   PubMed Web of Science ®Google Scholar
• Slotema CW, Blom JD, Hoek HW, Sommer IEC. Should we expand the toolbox of psychiatric treatment methods to include repetitive transcranial magnetic stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders. J. Clin. Psychiatry71(7), 873–884 (2010).
   PubMed Web of Science ®Google Scholar
• Dlabac-de Lange JJ, Knegtering R, Aleman A. repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: review and meta-analysis. J. Clin. Psychiatry71(4), 411–418 (2010).
   PubMed Web of Science ®Google Scholar
• Rector NA, Beck AT, Stolar N. The negative symptoms of schizophrenia: a cognitive perspective Can. J. Psychiatry50(5), 247–257 (2005).
   PubMed Web of Science ®Google Scholar
• Beck AT, Rector NA. Cognitive approaches to schizophrenia: theory and therapy. Annu. Rev. Clin. Psychol.1, 577–606 (2005).
   PubMed Web of Science ®Google Scholar
• Blanchard JJ, Kring AM, Horan WP, Gur R. Toward the next generation of negative symptom assessments: the collaboration to advance negative symptom assessment in schizophrenia. Schizophr. Bull.37(2), 291–299 (2011).
   PubMed Web of Science ®Google Scholar
• Forbes C, Blanchard JJ, Bennett M, Horan WP, Kring A, Gur R. Initial development and preliminary validation of a new negative symptom measure: the Clinical Assessment Interview for Negative Symptoms (CAINS). Schizophr. Res.124(1–3), 36–42 (2010).
   PubMed Web of Science ®Google Scholar